Jaundice is the most common reason for admission during the 1st month of life. Multiple variables (maternal, infantile, during labor and environmental factors) affect the course and severity of jaundice (
1). Although there may be a benefit to patients with mild hyperbilirubinemia, the subjects with high elevation of serum bilirubin are endangered due to accumulation of bilirubin in the brain tissue (
1,
2). Enhanced enterohepatic circulation of bilirubin (EHC) that can occur with resection or bypass in adults or ileal inflammation leads to hypersecretion of bilirubin into the bile with increased formation of black pigment gall stones (
3,
4). Since active transport for non-conjugated bilirubin is not proved in the intestine, bilirubin may cycle only via passive diffusion under certain conditions (
3-
5). Interestingly, two thirds of bilirubin enter the systemic circulation; the remainder reabsorbed from the intestine is removed from blood by the liver (
3-
7). The final product of heme protein catabolism is an unconjugated bilirubin produced in the reticuloendothelial cells after a chain of enzymatic reactions by the oxygenase, reductase and non-enzymatic reducing agents. Conjugated bilirubin pigments can also be partly due to the deposition of the final product conjugations in hepatocyte by the enzyme bilirubin UDP-glucuronosyl transferase to form a polar water-soluble bilirubin glucuronide (
8). One of the factors that affect the severity and incidence of jaundice is the level of serum zinc.
Physiopathology of idiopathic jaundice is unknown in the neonates. Animal studies show that oral administration of zinc decreases serum bilirubin level in the rats. Mendez-Sanchez et al. showed that zinc salts can deposit unconjugated bilirubin and that zinc sulfate suppressed enterohepatic circulation of bilirubin in hamsters (
8). Consistent with the study by Vreman et al. who reported that zinc is an inhibitor of heme oxygenase enzyme in both in vitro and in vivo. Administration of zinc (4 μumol/kg) decreased carbon monoxide (CO) and bilirubin levels significantly one to six hours after treatment (
9). Zinc salts and other elements such as strontium inhibit the hem-oxygenase enzymes and as a result may prevent jaundice (
10).